A transient increase in collagen VI expression precedes the accumulation of collagen I associated with interleukin-4 (IL-4)-induced mineralization in human osteoblast-like cells. Transfection with an antisense oligonucleotide speciˆc for a1(VI) collagen mRNA was shown to attenuate mRNA levels of collagens VI and I. Incubating IL-4 treated cells with anti-collagen VI antiserum decreased expression of a1(I) mRNA. The results suggest that collagen VI may regulate collagen I expression in the early phase of IL-4-induced mineralization.
Previous studies have indicated that osteoblasts initiate synthesis of extracellular matrix proteins, particularly collagen I, during the early stages of diŠerentiation. 1, 2) It has been shown that collagen I plays important roles not only as a guide for calciˆca-tion in bone tissue but also as a regulator of osteoblast diŠerentiation. 3, 4) We have previously reported that recombinant human interleukin-4 (rhIL-4) increased collagen I and osteocalcin accumulation and caused mineralization in normal human periosteal osteoblast-like cells, named SaM-1 cells. 5) The rhIL-4 also transiently elevated the mRNA levels for a1(VI) and a2(VI) collagens and the accumulation of collagen VI in the cell layer. 6, 7) Collagen VI expression peaked at day 5, and the a1(I) procollagen mRNA level was greatest at day 10 after treatment with rhIL-4 for 72 h, suggesting that deposition of collagen VI into the extracellular matrix may be a prerequisite for the increase in collagen I expression. 7) Immunological and biochemical studies have established that collagen VI is a ubiquitous component of most connective tissues, where it usually exists as a heterotrimer of three genetically distinct a chains termed a1(VI) and a2(VI) (both of 140 kDa) and a3(VI) (250 kDa). 8, 9) Collagen VI appears to be involved in the structural stabilization of the extracellular matrix via a direct interaction with other macromolecules, including collagen I. 10) Collagen VI has been reported to be a signiˆcant constituent of cartilaginous matrices 11) and fetal bone. 12) Although the amount of collagen VI has been found to be low in mature bone, 13) decreased levels have been reported in some cases of osteoporosis. 14) Another study has detected the continuous presence of a2(VI) collagen mRNA in callus tissue, suggesting that this collagen is produced throughout the fracture-healing process. 15) Interestingly, the transient expression of collagen VI mRNAs has also been reported during the diŠerentiation in vitro of a range of cell types including chondrocytes, 16) muscle cells, 17) and adipose cells.
18)
The aim of this study was to clarify the role of collagen VI in the in vitro mineralization induced by rhIL-4 in SaM-1 cell cultures. We have used an antisense oligonulceotide (ASODN) to a1(VI) collagen mRNA to suppress the transient up-regulation of collagen VI expression by rhIL-4 and identify the eŠect on the expression of a range of bone-related genes using a semiquantitative reverse transcriptase polymerase chain reaction (SQ RT-PCR) and immunoblot analysis. Furthermore, we have added speciˆc anti-collagen VI antibodies to the cultures to disrupt the extracellular function of the molecule.
SaM-1 cells, demonstrating functional and morphological characteristics typical of osteoblasts, were cultured as previously reported. 7, 19) More than 90z of the collagen they produced was type I. 19) SaM-1 cells were cultured with or without 3.0 ng W ml rhIL-4 (kindly supplied by Ono Pharmaceutical, Japan). Transfection with an antisense oligonucleotide (ASODN) for the a1(VI) collagen chain was done as follows. An ASODN (5?-AGAGCACGGGCCGC-CCTCAT-3?) complementary to a sequence directly downstream from the initiation codon of a1(VI) collagen 20) was selected, as it was particularly eŠective in blocking collagen VI synthesis in preliminary experiments (not shown). The corresponding control sense oligonucleotide (SODN) was 5?-ATGAGGGCGG-CCCGTGCTCT-3?. Both were synthesized as phosphorothionate oligonucleotides and subsequently puriˆed, using high pressure liquid chromatography, by Toa Gosei Ltd. Japan. 21) For transfection, 5 mM of each oligonucleotide was mixed with 3 ml of FuGENE 6 (Roche Diagnostics) in medium (400 ml) containing 1.2 ng of rhIL-4 and 10z FBS, and added to subcon‰uent SaM-1 cells in 24-well multiwell plates (Becton Dickinson) according to the manufacturer's instructions. The cells were then incubated for a further 72 h and total RNA was isolated as described below. Transfection with either oligonucleotide did not aŠect cell number, cell growth, or viability (data not shown). Total RNA was prepared from SaM-1 cells by the acid guanidine-phenol-chloroform method. 22) First-strand cDNA libraries were made from total RNA by using random primers (Takara, Japan) and Moloney Murine Leukaemia Virus reverse transcriptase (Toyobo, Japan) as described by the manufacture's instructions. PCR was done in a 50-ml reaction containing 1×PCR reaction buŠer, 200 mM dNTPs, 2 mM MgCl2, 1 ml of single strand cDNA solution, 1.25 units of Amplitaq Gold DNA polymerase (Applied Biosystems), and 0.6 mM of sense and antisense primers (Table 1) . Ampliˆcations were done by incubation in a GeneAmp 9700 thermal cycler (Applied Biosystems) using step-cycle programs under the linear ampliˆcation conditions. The PCR program was as follows: 949 C for 45 s, 559 C for 40 s, and 729 C for 1 min for a1(I) collagen, a1(VI) collagen, alkaline phosphatase (ALP), CBFA1, and glyceraldehyde-3-phophate dehydrogenase (GAPDH); 949 C for 45 s, 709 C for 40 s, and 729 C for 30 s for a1(III) collagen and osteonectin (ON); 949 C for 45 s, 629 C for 30 s, and 729 C for 30 s for osteocalcin (OC). The PCR products were electrophoresed on a 2z agarose gel and made visible by ethidium bromide staining with ultraviolet light illumination. The internal control for RT-PCR was GAPDH mRNA. The authenticity of all PCR products was conˆrmed by sequencing.
First, SQ RT-PCR analysis was used to conˆrm that the ASODN speciˆcally attenuated the level of a1(VI) collagen mRNA in the rhIL-4 treated SaM-1 cells (Fig. 1A) . Clearly transfection of the cells with the ASODN resulted in markedly less a1(VI) collagen cDNA by RT-PCR than those transfected with the SODN. In contrast, no diŠerences were observed in the amounts of GAPDH amplicon between the two treatments, demonstrating that the two oligonucleotides had no discriminating eŠects on this control gene and that the RNA samples had equal e‹ciency of cDNA synthesis. The eŠect of the antisense attenuation of the a1(VI) collagen mRNA level on the expression of various genes associated with osteoblastic diŠerentiation was also investigated. Using SQ RT-PCR, relative mRNA levels for a1(I) collagen, a1(III) collagen, ALP, CBFA1, OC, and ON were measured (Fig. 1B) . CBFA1 expression was examined, as a key role of this runt-containing transcription factor has recently been identiˆed in the regulation of bone cell diŠerentiation. 23, 24) Collagen III has been already identiˆed in SaM-1 cells. 25) Messenger RNAs for each of these mRNAs were detected in the SaM-1 cells by SQ RT-PCR. No diŠerences were detected in mRNA levels for ALP, CBFA1, OC, ON, and GAPDH between the cells treated with the SODN and the ASODN of a1(VI) collagen. However, there was a signiˆcant reduction in the level of a1(I) collagen mRNA, and a slight reduction in the level of a1(III) collagen mRNA, in the cells (A) SQ RT-PCR analysis of mRNA levels for a1(VI) collagen and GAPDH. SaM-1 cells were cultured for 72 h with the a1(VI) collagen SODN (S) or ASODN (AS) in the medium also containing rhIL-4 (3.0 ng W ml). The mRNA encoding a1(VI) collagen (a1(VI)) was ampliˆed by SQ RT-PCR after normalization with GAPDH expression as described in the text. (B) SQ RT-PCR analysis of osteoblast marker mRNA levels. The mRNAs encoding a1(I) collagen (a1(I)), a1(III) collagen (a1(III)), ALP, CBFA1, OC, and ON were ampliˆed by SQ RT-PCR after normalization with GAPDH expression. Reaction products were made visible on ethidium bromide-stained agarose gels. transfected with the ASODN of a1(VI) collagen relative to cells treated with the control SODN. We conrmed that the ASODN of a1(VI) collagen did not directly block a1(I) collagen mRNA expression in the cultured SaM-1 cells without rhIL-4 (data not shown). Thus the suppression of rhIL-4-induced a1(VI) collagen mRNA up-regulation by antisense treatment also appeared to have the relatively speciˆc eŠect of attenuating the rhIL-4-induced up-regulation of a1(I) collagen mRNA expression.
Toˆnd if the antisense treatment of a1(VI) collagen also attenuated the accumulation of collagens VI and I by IL-4 treated SaM-1 cells, cell layer extracts were immunoblotted for these collagens and the intensities of the antibody-staining bands were measured. Preparation of the cell lysate and immunoblot analyses of collagens VI, I and GAPDH in the cell lysates were done as described previously. 7) Antibodies were obtained from Chemicon (anti-human collagen I antibody) and Trevigen (anti-human GAPDH antibody). The rabbit polyclonal antiserum to collagen VI was described previously. 7) Relative amounts of collagens VI, I and GAPDH on western blots were then measured using a CS-9000 dual-wavelength ‰ying-spot scanner (Shimadzu, Japan). The ASODN-treated cultures showed reduced protein levels of a1(VI), a2(VI) and a3(VI) collagens with values of 46z, 39z, and 45z respectively, relative to the values obtained from cultures treated with the control SODN (Table 2) . Interestingly, the ASODN treatment also reduced the relative protein levels of a1(I) and a2(I) collagens to about 46 and 37z, respectively, of the SODNs control. Thus transfection of the ASODN of a1(VI) collagen attenuated protein levels of collagen I as well as the mRNA levels. Further study is necessary to examine whether the attenuation of collagen I expression could be improved by exogenous collagen VI.
To investigate further the in‰uence of collagen VI protein on collagen I mRNA expression in the early stage of rhIL-4 induced mineralization, we added anti-collagen VI antiserum to cultures to perturb the normal function of extracellular collagen VI. The cells were treated with rhIL-4 (3.0 ng W ml) for 72 h, together with 1 W 400 dilution of rabbit anti-collagen VI antiserum (Ab). Control cultures contained no antiserum (Con) or a 1 W 400 dilution of preimmune rabbit serum (Pre). SQ RT-PCR analysis showed that the cultures treated with anti-collagen VI antiserum showed no eŠect on the expression of the mRNAs for a1(VI) collagen and GAPDH relative to the untreat- Cells were treated with rhIL-4 (3.0 ng W ml) and 1 W 400 diluted anti-collagen VI antiserum (Ab) for 72 h. Control cultures were incubated without antiserum (con), or with preimmune serum (pre). The mRNAs encoding a1(I) collagen (a1(I)), a1(III) collagen (a1(III)), and a1(VI) collagen (a1(VI)) were ampliˆed by SQ RT-PCR after normalization with GAPDH expression. Reaction products were made visible on ethidium bromide-stained agarose gels.
ed and preimmune treated control cultures (Fig. 2) . However the antiserum treatment signiˆcantly decreased expression of a1(I) collagen mRNA relative to the controls. A slight decreased in expression of a1(III) collagen mRNA was also noted. The results suggest that the observed modulation of collagen I expression in the IL-4 treated SaM-1 cells is speciˆcally mediated by the levels of extracellular collagen VI.
In this study, theseˆndings suggest that up-regulation of collagen I mRNA in rhIL-4 treated SaM-1 cells may be modulated by their interaction with collagen VI accumulated in the surrounding extracellular matrix. Thus, collagen VI may serve as a matrix-derived inducer of integrin-mediated collagen I expression in the early stages of osteoblastic diŠerentiation. In osteoblastic cell lines, except SaM-1 cells, the existence and function of collagen VI described here need to be examined. Moreover, it will be important to investigate the modulation of collagen I expression in osteoblast cultures isolated from collagen VI-deˆcient and IL-4-deˆcient bones.
A candidate cell surface receptor for collagen VI, a2b1 integrin, was identiˆed on the SaM-1 cells by immunoblot analysis (data not shown). Forced expression of a2b1 integrin has recently been shown to up-regulate a1(I) procollagen mRNA transcription by osteosarcoma cells in response to contact with three-dimensional collagen. The signalling has been found to be mediated by p38 mitogen-activated protein kinase. 26) Moreover a2b1 integrin is known to bind collagen VI 27) and a signal transduction pathway for collagen VI involving the a1 integrin has been partly described forˆbroblasts. 28) However, it should be noted that collagen VI also associates with several other transmembrane receptors such as a2b1 integrin 27) and the transmembrane proteoglycan NG2. 29) A number of extracellular modulators of collagen I expression have been identiˆed. It has been shown, using rat calvaria RNA in a reticulocyte cell-free translation system, that amino-terminal peptides of a1(I) and a1(III) procollagen chains inhibit the production of a1(I) and a2(I) procollagen chains. 30) Recently, SPARC (secreted protein acidic and rich in cysteine), a matricellular glycoprotein (also known as BM-40, osteonectin, or 43-kDa protein) has been shown to regulate the expression of collagen I via activation of the TGF-b signalling pathway in mouse mesangial cells. 31) Further studies will focus on the identiˆcation of the signaling pathway in SaM-1 cells activated by collagen VI andˆnding if its up-regulation of collagen I gene expression involves direct or indirect signalling.
